Accent Therapeutics: Funding, Investors & Team (Oct 2026)
Accent Therapeutics is a biopharmaceutical company developing oncology-focused, small molecule therapies in the emerging field of epitranscriptomics. This field of biology encompasses post-transcriptional chemical modifications of RNA that provide cells with a unique mechanism for regulating proteins critical for cellular growth and differentiation. By targeting cancer-linked RNA-modifying proteins (RMPs) with precision therapies, they aim to translate extraordinary science into life-changing therapies for patients.
Accent Therapeutics has raised $63.0M across 1 funding round on record, the most recent an undisclosed round of $63.0M announced in Apr 2020.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Accent Therapeutics Company Profile and Key Stats
Latest funding round on record: Apr 2020.
Accent Therapeutics Funding Rounds
Accent Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Accent Therapeutics Funding Compared to Other Biotechnology Startups
Accent Therapeutics' latest round of $63.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Accent Therapeutics in Biotechnology and Lexington
Companies Similar to Accent Therapeutics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Accent Therapeutics Funding FAQs
What does Accent Therapeutics do?
Accent Therapeutics is a biopharmaceutical company developing oncology-focused, small molecule therapies in the emerging field of epitranscriptomics. This field of biology encompasses post-transcriptional chemical modifications of RNA that provide cells with a unique mechanism for regulating proteins critical for cellular growth and differentiation. By targeting cancer-linked RNA-modifying proteins (RMPs) with precision therapies, they aim to translate extraordinary science into life-changing therapies for patients.
How much funding has Accent Therapeutics raised?
Accent Therapeutics has raised $63.0M across 1 round on record. The most recent is an undisclosed round of $63.0M announced in Apr 2020.
When did Accent Therapeutics last raise funding?
Accent Therapeutics' most recent funding round on record is an undisclosed round of $63.0M, announced in Apr 2020.
Who is the CEO of Accent Therapeutics?
Shakti Narayan is listed as CEO at Accent Therapeutics.
Where is Accent Therapeutics headquartered?
Accent Therapeutics is based in Lexington, Kentucky, United States.
How many employees does Accent Therapeutics have?
Accent Therapeutics is in the 11-50 employee band.
How does Accent Therapeutics' funding compare to other Biotechnology startups?
Accent Therapeutics' latest round of $63.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Accent Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Accent Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.